Search

2015 is almost over, thank the Lord! The stock market lacked momentum, trading sideways virtually the entire year.

Many of the undervalued growth stocks that I follow have neutral or bearish price charts right now. No doubt they’re tuckered out from the bullish price action in 2017!

Today’s recommendation is a stock that you may never have heard of, and there are pros and cons to that. But it will certainly bring diversification to the portfolio, and I leave it to you to decide if the stock is right for your portfolio as well.

Today’s stock is a name you’ll know. The company was born in the early days of the internet and today it’s all grown up—a major player in the world of financial transactions.

The market’s main trends remain up, and thus I remain bullish, while continuing to remind you that a balanced portfolio with attention to risk management is always smart.

The broad market remains strong, and all Cabot’s market timing indicators are currently positive, so I remain optimistic that we’ll see higher prices in the month ahead.

This week’s recommendation is a growth-oriented medical stock with great potential; it was originally recommended by Mike Cintolo last November and it’s currently hitting new highs.



And as for the current portfolio, most of our stocks look fine, but because I limit the portfolio to 20 stocks, one has to go—and it’s the weakest.



Details in the issue.

The broad market remains strong, and all Cabot’s market timing indicators are currently positive, so I remain optimistic that we’ll see higher prices in the month ahead and I continue to recommend that you remain heavily invested. However, it’s worth noting that the market is increasingly ripe for a pullback, and that a few of our super-strong stocks (LK and SPCE and TSLA) are also ripe for major pullbacks. In other words the market looks a bit overheated here.

Thus this week’s recommendation is a lower-risk, high-yielding chemical stock with very little downside potential. I think it will balance those higher-risk stocks nicely. Lastly, the addition of this stock means we have to sell one, and the victim this week is TopBuild (BLD).



Details in the issue.

Many Smart Investing portfolio stocks are trading in narrow, sideways price ranges, since having a strong initial rebound from the winter’s stock market correction. Those trading ranges give us good guidance on how to proceed with stocks.

In choosing today’s stock, I leaned conservative, and found a dividend-paying stock with strong growth prospects. When I selected it yesterday, the stock was at the bottom of its recent range, but today it shot up to near the top of that range. It’s still a good story, but I’d like it better where it was yesterday.

Hindenburg Research’s announcement that they’ll be closing up shop has made Carvana (CVNA) their final short target. Here is their rationale.

USA Technologies (USAT) reported a mixed bag of quarterly results this morning. I think buying here has a relatively high probability of working out within a 30-day window.

Today, I’m adding an American petroleum contract drilling company, Helmerich & Payne, Inc. (HP).

One stock moves from Hold to Buy, one moves from Hold to Sell, and we have earnings reports on five stocks.

Revolutionary stocks not only have rapid growth, but also have the potential to get much larger.

Two of our positions reported strong fourth-quarter results and one reported an earnings miss. On top of that, two of our positions have seen some interesting price action.

Tunisian leader Zine El Abadine Ben Ali was in power for 23 years before widespread protests forced him to retire on January 14. Hosni Mubarak was president of Egypt for 30 years before resigning on February 11. And Muammar al-Gaddafi has been in control of Libya for a staggering 42...

As long as banks can borrow from the Fed almost for free, yields on high-quality debt will remain at historical lows.

Two stocks blastoff after reporting earnings.

Here are the biggest winners of 2012. I got this list by screening all stocks that trade on U.S. exchanges.

Virgin Galactic (SPCE), Richard Branson’s space tourism company, is a revolutionary idea, and SPCE stock is on the brink of heading into the stratosphere.